Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)

NCT05831007 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators